Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

Why I think rare disease companies are more patient-centric

Guest blogger Kamlesh Sheth believes companies that specialise in rare disease tend to be more patient-centric.

Say Communications

Roche Basel Switzerland

Roche claims its own CAR-T first with orphan drug Actemra

Comes as FDA approves the first CAR-T therapy from Novartis

- PMLiVE

Turnstone Biologics bolsters leadership team

Kris Elverum and José Otero join the group

- PMLiVE

Proving real-world value

A focus on the industry

- PMLiVE

FDA clears Teva’s tardive dyskinesia drug Austedo

The twice-daily drug will compete with Neurocrine Bioscience’s Ingrezza

- PMLiVE

NICE backs Allergan’s IBS therapy Truberzi

The £3 per day therapy was recommended in final guidance from the cost-effectiveness watchdog

- PMLiVE

The importance of culture and diversity of talent

Unlocking your agency MOJO

“Legal highs” ruling leaves illegal labs laughing

In a test case yesterday, a judge said yes to NO

Life Healthcare Communications

Empathology: The science of being someone else

If you can see the world from your customer's perspective, you have discovered the secret of empathy

Life Healthcare Communications

How to be a patient

Doctors are trained on how to manage their patients. Now Which? magazine has published a guide for patients on how to get the most out of their GP

Life Healthcare Communications

- PMLiVE

UK life sciences sector sets out its post-Brexit growth proposals

Review helmed by Sir John Bell outlines a wide-ranging strategy

- PMLiVE

J&J expands its TB research programme

Partners with Indian groups CSIR and IMTECH to develop new treatments

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links